SOUTHERN PHOSPHATE CORP.
v.
PHOSPHATE RECOVERY CORP.

U.S. | 1939-05-29
No. 934
307 U.S. 649 Supreme Court of the United States (1939) Positive Treatment
Cited by 5 cases

Opinion

Full opinion text not available for this case.


Cases With Similar Vibessemantic neighbors from the corpus


Citator

Cited By

  • …ons of service, the statute required continuous operation from June 1,1935, until the hearing by the Commission on the application. We have, however, held to the contrary. United States v. Maher, 307 U. S. 148, petition for limited rehearing denied, 307 U. S. 649. Hoey v. United States, 308 U. S. 510; Lubetich v. United States, 315 U. S. 57. Appellants contend alternatively that the Commission should be reversed for refusing to hold that the applicant “had no control” over the cessation of operations. From…
  • Anton Lorenz v. F. W. Woolworth Co., 305 F.2d 102 (2d Cir. 1962)
    …egate the presumption. Cutler Mail Chute Co. v. Capitol Mail Chute Corp., 118 F. 2d 63, 64 (2d Cir.), cert. denied, 313 U.S. 580, 61 S.Ct. 1096, 85 L.Ed. 1537 (1941); Celanese Corp. v. Essley, 98 F. 2d 895 (2d Cir.1938) petition for cert. dismissed, 307 U.S. 649, 59 S.Ct. 836, 83 L.Ed. 1528 (1939); R. Hoe & Co. v. Goss Printing Press Co., 30 F. 2d 271, 274 (2d Cir.1929); see Alco Kar Kurb Inc. v. Ager, 286 F. 2d 931 (3d Cir.1961). However, although it is not clear whether he is correct, appellant argues tha…
  • CMI Corp. v. Metro. Enters., Inc., 534 F.2d 874 (10th Cir. 1976)
    …gh the presumption may be overcome by clear proof. S. H. Kress & Co. v. Aghnides, 246 F. 2d 718, 721 (4th Cir.), cert. denied, 355 U.S. 889, 78 S.Ct. 261, 2 L.Ed.2d 189; Celanese Corp. v. Essley Shirt Co., 98 F. 2d 895, 896 (2d Cir.), cert. denied, 307 U.S. 649, 59 S.Ct. 836, 83 L.Ed. 1528. We feel that proof to overcome the presumption and carry the burden of showing invalidity was not made. See 35 U.S. C.A. § 282. In sum, we believe the findings of non-obviousness, no anticipation, and of invention are…

Previewing 3 of 5 citing cases — full citator treatment, depth of discussion, and citing context are member features.

Join FLexlaw to unlock all legal intelligence

Full citator, related cases, and AI research tools

Open in FLexlaw